
UnitedHealth Group, Cencora, and McKesson are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. “Medical stocks” are publicly traded shares of companies that operate in the healthcare and medical industries, including pharmaceuticals, biotechnology, medical device manufacturers, diagnostics, and healthcare providers. Investors typically treat them as a way to gain exposure to drug development, medical technology and healthcare services, while weighing sector-specific factors such as regulatory approval, clinical trial outcomes, patent protection and reimbursement policies. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Cencora (COR)
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
Read Our Latest Research Report on COR
McKesson (MCK)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Read Our Latest Research Report on MCK
Read More
- MarketBeat’s Top Five Stocks to Own in May 2026
- Apple Talks Just Changed Everything for Intel
- Consolidate or Die: Is Rivian The Ultimate Takeover Target?
- Boarding Passes Now Being Issued for the Ultimate eVTOL Arbitrage
- Western Digital: The Storage Behemoth Skyrocketing on AI Demand
- Old Money, New Tech: Western Union’s Crypto Reboot
